XTX Topco Ltd lifted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 81.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 58,415 shares of the real estate investment trust's stock after acquiring an additional 26,253 shares during the period. XTX Topco Ltd's holdings in Sabra Healthcare REIT were worth $1,021,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its holdings in Sabra Healthcare REIT by 379.6% in the 1st quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after purchasing an additional 1,621 shares during the last quarter. Assetmark Inc. lifted its holdings in Sabra Healthcare REIT by 37.8% in the 1st quarter. Assetmark Inc. now owns 3,607 shares of the real estate investment trust's stock worth $63,000 after purchasing an additional 989 shares during the last quarter. Fifth Third Bancorp lifted its holdings in Sabra Healthcare REIT by 110.3% in the 1st quarter. Fifth Third Bancorp now owns 3,835 shares of the real estate investment trust's stock worth $67,000 after purchasing an additional 2,011 shares during the last quarter. GF Fund Management CO. LTD. acquired a new stake in Sabra Healthcare REIT in the 4th quarter worth approximately $74,000. Finally, Harbor Capital Advisors Inc. lifted its holdings in Sabra Healthcare REIT by 17.2% in the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock worth $76,000 after purchasing an additional 642 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.
Sabra Healthcare REIT Price Performance
Shares of NASDAQ SBRA traded up $0.30 during midday trading on Thursday, reaching $18.71. 1,484,532 shares of the company traded hands, compared to its average volume of 2,432,012. The firm has a market cap of $4.45 billion, a PE ratio of 24.57, a PEG ratio of 1.51 and a beta of 0.86. The stock's 50-day simple moving average is $18.20 and its 200-day simple moving average is $17.52. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.22 and a current ratio of 4.80.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%. The company's revenue was up 7.4% on a year-over-year basis. During the same period last year, the company earned $0.36 earnings per share. As a group, equities analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.4%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is presently 157.89%.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on SBRA shares. Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $20.00.
Get Our Latest Research Report on SBRA
Insider Transactions at Sabra Healthcare REIT
In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the transaction, the director owned 64,725 shares of the company's stock, valued at $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.20% of the company's stock.
About Sabra Healthcare REIT
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.